AUSTRALIS Completes Definitive Agreement to Acquire Green Therapeutics LLC
News provided by
Share this article
Foundational Asset in AUSA s Multi-State Footprint
Acquisition Agreement Includes Resolution of Litigation by Unwinding Original Transaction
LAS VEGAS, March 12, 2021 /PRNewswire/ - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ( AUSA or the Company ) today announced that, further to the Company s press release of January 5, 2021, AUSA has entered into a definitive agreement on March 11, 2021 with, among others, Green Therapeutics LLC ( GT ) and the holders of the issued and outstanding membership interests of GT concerning the acquisition of GT.
The transaction will be completed in two parts, the first being the acquisition of a subsidiary of GT (the Subsidiary ) containing a number of unregulated assets including the GT brands and certain ancillary agreements including brand licensing and management agreements. Subsequently, subject to regulatory approval, the C
Australis to Acquire Green Therapeutics LLC
News provided by
Share this article
Operationalizes AUSA with Multi-State Footprint
Acquisition Agreement Includes Resolution of Litigation by Unwinding Original Transaction
LAS VEGAS, Jan. 5, 2021 /PRNewswire/ - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ( AUSA or the Company ) today announced that the Company has entered into a non-binding term sheet dated January 4, 2020 with Green Therapeutics LLC ( GT ) and the holders of the issued and outstanding membership interests of GT setting forth the terms of a proposed transaction pursuant to which Australis will purchase 100% of the issued and outstanding membership interests in GT. Prior to completing the acquisition, the parties have agreed to settle a previously announced legal dispute regarding the original May 2019 transaction whereby AUSA had acquired certain non-operational GT assets.